London enrolment for Roche clinical trial
We are excited to let you know that the recently announced Roche clinical trial is taking place in the UK too. Dr Andre Strydom at University College London is studying a medication that is being developed to improve attention and memory in people with Down Syndrome.
It is a multi-center, randomized, double-blind, placebo-controlled, multiple dose study to investigate safety and tolerability of RG1662 in individuals with Down Syndrome. We are pleased that Roche have extended enrolment to London.
Dr Strydom can be contacted at a.strydom@ucl.ac.uk ; or on +44 (0)2076799467 and please leave a message
US Charity DSRTF recently hosted an evening discussing this trial which can be viewed
Roche Clinical Trial Protocol Registry
Please contact Dr Strydom for more information and to discuss being involved with this study.
Leaflet available here
|
|
|
|
|
